Literature DB >> 12805114

Huntington's disease-like phenotype due to trinucleotide repeat expansions in the TBP and JPH3 genes.

Giovanni Stevanin1, Hiroto Fujigasaki, Anne-Sophie Lebre, Agnes Camuzat, Cecile Jeannequin, Catherine Dode, Junko Takahashi, Chankranira San, Robert Bellance, Alexis Brice, Alexandra Durr.   

Abstract

We report a group of 252 patients with a Huntington's disease-like (HDL) phenotype, including 60 with typical Huntington's disease, who had tested negative for pathological expansions in the IT15 gene, the major mutation in Huntington's disease. They were screened for repeat expansions in two other genes involved in HDL phenotypes: those encoding the junctophilin-3 (JPH3/HDL2) and prion (PRNP/HDL1) proteins. In addition, because of the clinical overlap between patients with HDL disease and autosomal dominant cerebellar ataxia or dentatorubral and pallidoluysian atrophy (DRPLA), we investigated trinucleotide repeat expansions in genes encoding the TATA-binding protein (TBP/SCA17) and atrophin-1 (DRPLA). Two patients carried 43 and 50 uninterrupted CTG repeats in the JPH3 gene. Two other patients had 44 and 46 CAA/CAG repeats in the TBP gene. Patients with expansions in the TBP or JPH3 genes had HDL phenotypes indistinguishable from Huntington's disease. Taking into account patients with typical Huntington's disease, their frequencies were evaluated as 3% each in our series of typical HDL patients. Interestingly, incomplete penetrance of the 46 CAA/CAG repeat in the TBP gene was observed in a 59-year-old transmitting, but healthy, parent. Furthermore, we report a new configuration of the expanded TBP allele, with 11 repeats on the first polymorphic stretch of CAGs. Expansions in the DRPLA gene and insertions in the PRNP gene were not found in our group of patients. Further genetic heterogeneity of the HDL phenotype therefore exists.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12805114     DOI: 10.1093/brain/awg155

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  44 in total

1.  Basal ganglia involvement of a patient with SCA 17--a new form of autosomal dominant spinocerebellar ataxia.

Authors:  P Günther; A Storch; J Schwarz; O Sabri; P Steinbach; A Wagner; S Hesse
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

Review 2.  Immuno-proteomic approach to excitation--contraction coupling in skeletal and cardiac muscle: molecular insights revealed by the mitsugumins.

Authors:  Noah Weisleder; Hiroshi Takeshima; Jianjie Ma
Journal:  Cell Calcium       Date:  2007-12-03       Impact factor: 6.817

3.  Huntington's disease and mitochondrial DNA deletions: event or regular mechanism for mutant huntingtin protein and CAG repeats expansion?!

Authors:  Mohammad Mehdi Banoei; Massoud Houshmand; Mehdi Shafa Shariat Panahi; Parvin Shariati; Maryam Rostami; Masoumeh Dehghan Manshadi; Tayebeh Majidizadeh
Journal:  Cell Mol Neurobiol       Date:  2007-10-20       Impact factor: 5.046

4.  JPH3 repeat expansions cause a progressive akinetic-rigid syndrome with severe dementia and putaminal rim in a five-generation African-American family.

Authors:  Susanne A Schneider; Kate E Marshall; Jianfeng Xiao; Mark S LeDoux
Journal:  Neurogenetics       Date:  2012-03-25       Impact factor: 2.660

Review 5.  Diagnosis and treatment of chorea syndromes.

Authors:  Andreas Hermann; Ruth H Walker
Journal:  Curr Neurol Neurosci Rep       Date:  2015       Impact factor: 5.081

6.  The University of Washington Health Sciences Library BioCommons: an evolving Northwest biomedical research information support infrastructure.

Authors:  Mark Minie; Stuart Bowers; Peter Tarczy-Hornoch; Edward Roberts; Rose A James; Neil Rambo; Sherrilynne Fuller
Journal:  J Med Libr Assoc       Date:  2006-07

7.  Junctophilin 3 (JPH3) expansion mutations causing Huntington disease like 2 (HDL2) are common in South African patients with African ancestry and a Huntington disease phenotype.

Authors:  Amanda Krause; Claire Mitchell; Fahmida Essop; Susan Tager; James Temlett; Giovanni Stevanin; Christopher Ross; Dobrila Rudnicki; Russell Margolis
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2015-06-16       Impact factor: 3.568

Review 8.  Antisense oligonucleotides: rising stars in eliminating RNA toxicity in myotonic dystrophy.

Authors:  Zhihua Gao; Thomas A Cooper
Journal:  Hum Gene Ther       Date:  2013-01-30       Impact factor: 5.695

Review 9.  Huntingtin and the molecular pathogenesis of Huntington's disease. Fourth in molecular medicine review series.

Authors:  Christian Landles; Gillian P Bates
Journal:  EMBO Rep       Date:  2004-10       Impact factor: 8.807

Review 10.  Spinocerebellar ataxia type 17 is caused by mutations in the TATA-box binding protein.

Authors:  Christine Zühlke; Katrin Bürk
Journal:  Cerebellum       Date:  2007-01-19       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.